Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07167719

Resilience in Reentry: Cognitive-Behavioral Resilience Training for Parolees With Adjustment Challenges

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot study assesses the feasibility and acceptability of delivering a brief Cognitive-Behavioral Resiliency treatment to a population of recently released parolees. This study will also give a preliminary indication if the treatment is associated with reliable improvements in adjustment symptoms and well-being for parolees.

Detailed description

In the proposed pilot study, residents of a reentry facility in Los Angeles, CA will be able to enroll in a course of brief (5-session) Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization. Those who choose to receive the intervention will be included in the intervention group (target N = 30). Those who choose not to receive the intervention will be given the opportunity to complete assessments at the same intervals as the intervention group (assessment only group; target N = 30). Participants will report their degree of satisfaction with the program and how much they think they benefitted from the program at postintervention. Participants will complete self-report measures of adjustment disorder symptoms, flourishing, meaning and purpose in life, and PTSD symptoms at pretreatment (baseline), posttreatment (5 weeks after baseline), and 2-month follow-up (13 weeks after baseline).

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Behavioral TherapyBrief Cognitive-Behavioral Therapy (CBT) focused on building resiliency in response to the effects of institutionalization

Timeline

Start date
2026-01-27
Primary completion
2026-09-01
Completion
2026-12-01
First posted
2025-09-11
Last updated
2026-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07167719. Inclusion in this directory is not an endorsement.